Dissolution and bracketing [Regulatives / Guidelines]

posted by Susanh – Iceland, 2020-04-03 13:56 (1040 d 03:20 ago) – Posting: # 21314
Views: 1,898

Hi and thanks for your response.
Just to make sure I’m understanding correctly:
Do I need to do a BE study on all the strengths that are not showing similarity in dissolution
Or
Can I use bracketing approach and just add one study, either on the lowest strength or the strength differing most in dissolution?
Thanks for your help.
Susan

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
21 visitors (0 registered, 21 guests [including 4 identified bots]).
Forum time: 16:16 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5